Fenwick & West advised DexCare on the deal. DexCare, a data-driven intelligence company focused on healthcare access, announced its $50 million Series B financing. The round was...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Afero, while Ropes & Gray advised Crosspoint Capital Partners on the deal. Afero, a leading secure Internet of Things (IoT) Platform as...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Crossover Health in the transaction. Crossover Health, a relationship-based, tech-enabled, national healthcare organization that integrates both virtual and in-person care for...
You must be a Standard 1 Year member to access this content.
